Showing results (51-60 of 220) with videos related to
Sort By:
Pageof 22
Expert Opinion on Investigational Drugs|July 5, 2005
Advances in vaccine delivery: transcutaneous immunisationG M Glenn, T Scharton-Kersten, C R AlvingJournal of Pharmaceutical Sciences|December 1, 1996
Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicityR L Richards, C R Alving, N M WassefBiochemical and Biophysical Research Communications|April 30, 1991
Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipidsN M Wassef, G R Matyas, C R AlvingThe Journal of Laboratory and Clinical Medicine|January 1, 1975
Abnormal lipid composition of the red cell membrane in congenital dyserythropoietic anemia type II (HEMPAS)K C Joseph, J P Gockerman, C R AlvingBiochimica Et Biophysica Acta|October 2, 1987
Antibodies to phospholipids and liposomes: binding of antibodies to cellsW E Fogler, G M Swartz, C R AlvingJournal of Liposome Research|February 27, 2003
Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studiesJ Szebeni, L Baranyi, S Savay, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1977
Cholesterol-dependent human complement activation resulting in damage to liposomal model membranesC R Alving, R L Richards, A A GuirguisCanadian Journal of Physiology and Pharmacology|February 1, 1987
Effects on the murine mononuclear phagocyte system of chronic administration of liposomes containing cytotoxic drug or lipid A compared with empty liposomesT M Allen, L Murray, C R Alving, et al.Cancer Research|October 1, 1985
Metabolic fate of liposomal phosphatidylinositol in murine tumor cells: implications for the mechanism of tumor cell cytotoxicityM Jett, J Chudzik, C R Alving, et al.Pageof 22